252 studies found for:    "Whooping cough"
Show Display Options
Rank Status Study
21 Not yet recruiting Bordetella Pertussis Carriage in College-aged Students
Condition: Carriage of Bordetella Pertussis
Intervention:
22 Completed Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older
Conditions: Diphtheria;   Tetanus;   Poliomyelitis;   Pertussis
Intervention: Biological: Diphtheria, tetanus, polio and pertussis vaccination
23 Completed Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: Concomitant administration;   Biological: Separate administration
24 Recruiting Diphtheria, Tetanus, Poliomyelitis -Pertussis-Hib Immunisation in Preterm-born Neonates
Conditions: Hib Immunisation in Very Preterm-born Infants;   Pertussis Immunisation in Very Preterm-born Infants
Interventions: Biological: Three vaccine injections DTP-pertussis-Hib;   Biological: Two vaccine injections DTP-pertussis-Hib
25 Completed Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine
Conditions: Diphtheria;   Tetanus;   Whooping Cough;   Polio;   Haemophilus Influenzae Type b
Interventions: Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine);   Biological: Pentacel: DTaP-IPV/Hib
26 Completed
Has Results
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
Conditions: Tetanus;   Diphtheria;   Pertussis;   Whooping Cough
Interventions: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel®);   Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (BOOSTRIX®)
27 Not yet recruiting A Trial Comparing Two Pertussis-containing Vaccines in Pregnancy and Vaccine Responses in UK Mothers and Their Infants
Condition: Responses to Infant Immunisations in Babies Born to Mothers Who Were or Were Not Vaccinated Against Pertussis in Pregnancy.
Interventions: Drug: Repevax;   Drug: Boostrix-IPV
28 Enrolling by invitation Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose
Conditions: Tetanus;   Diphtheria;   Pertussis;   Whooping Cough
Interventions: Biological: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed;   Biological: Tetanus and Diphtheria Toxoids Adsorbed For Adult Use
29 Withdrawn A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)
Conditions: Rotavirus Gastroenteritis;   Diphtheria;   Tetanus;   Pertussis
Interventions: Biological: Rotavirus Vaccine, Live, Oral, Pentavalent;   Biological: Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP);   Biological: Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)
30 Completed Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
Conditions: Viral Hepatitis Vaccines;   Hepatitis A;   Cytomegalovirus;   Varicella-Zoster Virus;   Bordetella Pertussis Infection;   Herpes Simplex (1 and 2)
Intervention: Other: Serum sample
31 Completed
Has Results
Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Poliomyelitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Current Manufacturing Facility (CMF);   Biological: Comparator: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant (qHPV) Vaccine from Future Manufacturing Facility (FMF);   Biological: Comparator: REPEVAX™ (Concomitant);   Biological: Comparator: REPEVAX™ (Non-Concomitant)
32 Completed
Has Results
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)
Conditions: Neoplasms, Glandular and Epithelial;   Diphtheria;   Tetanus;   Whooping Cough;   Meningitis
Interventions: Biological: Comparator: Quadrivalent Human Papillomavirus (HPV) vaccine;   Biological: Comparator: Menactra™ (Concomitant);   Biological: Comparator: Adacel™ (Concomitant);   Biological: Comparator: Menactra™ (Non-concomitant);   Biological: Comparator: Adacel™
33 Completed Pertussis Vaccine in Healthy Pregnant Women
Conditions: Diphtheria;   Pertussis;   Tetanus
Interventions: Drug: Placebo;   Biological: Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed
34 Completed
Has Results
Safety and Immune Response of Different Pediatric Combination Vaccines.
Conditions: Diphtheria;   Polio;   Pertussis
Interventions: Biological: DAPTACEL®. (DTaP), IPOL®., and ActHIB®.;   Biological: Pentacel®: DTaP-IPV/Hib combined;   Biological: DTaP-IPV and ActHIB®
35 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
Condition: Pertussis
Interventions: Biological: diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis;   Biological: diphtheria-tetanus vaccine
36 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines
Condition: Pertussis
Interventions: Biological: whole-cell pertussis vaccine;   Biological: diphtheria-tetanus vaccine
37 Completed Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.
Condition: Prophylaxis: Diphtheria, Tetanus and Pertussis
Intervention: Biological: Prophylaxis: Diphtheria, tetanus and pertussis
38 Completed
Has Results
Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous Dose
Conditions: Pertussis;   Tetanus;   Diphtheria
Intervention: Biological: Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®)
39 Completed
Has Results
A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and Older
Conditions: Pertussis;   Tetanus;   Diphtheria
Interventions: Biological: ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed;   Biological: DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed
40 Recruiting Post Marketing Surveillance for ADACEL™ in South Korea
Conditions: Diphtheria;   Tetanus;   Pertussis
Intervention: Biological: ADACEL™:Adsorbed Diphtheria, Tetanus Toxoids and Component Pertussis Combined

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years